Gallbladder Adenocarcinoma Responds to Chemo-Immunotherapy in Young Patient Without Gallstones
Feb 14, 2026
A 30-year-old female with stage IV gallbladder adenocarcinoma achieved complete metabolic resolution of metastases after three cycles of pembrolizumab, gemcitabine, and cisplatin, despite presenting without traditional risk factors.